UPDATE : Monday, June 25, 2018
상단여백
Gilead successfully switches HIV drug to Genvoya
Gilead Sciences Korea seems to have successfully switched its key drug in H...
by Nam Doo-hyun  |  2018-06-07 15:11
라인
Boehringer Ingelheim Korea appoints Steven Walter as CEO
Steven Walter has begun serving as the head of the Korean branch of Boehrin...
by Marian Chu  |  2018-06-07 10:52
라인
Sanofi Pasteur loses license for flu vaccine IDflu
Sanofi Pasteur has lost local approval for its intradermal influenza vaccin...
by Lee Hye-seon  |  2018-06-07 10:52
라인
Yuhan unveils clinical results for immunotherapy agent
Yuhan Corp. and Genosco have presented the results of phase 1 and 2 clinica...
by Lee Han-soo  |  2018-06-07 10:26
라인
Sanofi-Aventis Korea releases dyslipidemia therapy
Praluent Sanofi-Aventis Korea Tuesday launched dyslipidemia therapy Pralu...
by Marian Chu  |  2018-06-05 15:25
라인
‘Tug-of-war in Lipiodol pricing only hurts patients’
Guerbet Korea has recently come under fire for threatening to stop the supp...
by Nam Doo-hyun  |  2018-06-05 15:23
라인
SK Chemicals wins sales okay for chicken pox vaccine
SK Chemicals said Tuesday that it has gained marketing approval for Sky Var...
by Lee Han-soo  |  2018-06-05 14:23
라인
Viagra, Cialis overcome by generic copies
Original drugs in the erectile dysfunction treatment market, such as Viagra...
by So Jae-hyeon  |  2018-06-05 10:55
라인
Guerbet Korea accused of heavy-handed practices
Guerbet Korea has come under fire again for requesting 5-fold price hikes f...
by Marian Chu  |  2018-06-04 17:56
라인
US law expected to benefit Korean drugmakers
Korean developers of anticancer treatments and orphan drugs have welcomed a...
by So Jae-hyeon  |  2018-06-04 16:02
라인
Daewoong launches compound rhinitis treatment
Daewoong Pharmaceutical said Monday that it has launched Comekina (Ingredie...
by Lee Han-soo  |  2018-06-04 14:11
라인
Bridge Bio, Yuhan to co-develop immunotherapy agent
Bridge Biotherapeutics said Monday that it has signed an agreement to co-de...
by Lee Han-soo  |  2018-06-04 14:11
라인
Eisai picks Chong Kun Dang as dementia drug sales partner
Eisai Korea, the Korean unit of the Japanese pharmaceutical company, has ch...
by So Jae-hyeon  |  2018-06-04 14:10
라인
Xarelto results in fewer strokes and systemic emboli for frail NVAF patients: study
A new study shows Xarelto (ingredient: rivaroxaban) to result in fewer stro...
by Marian Chu  |  2018-06-01 12:09
라인
Teva Handok gets reimbursement for narcolepsy drug
Teva Handok’s once-daily narcolepsy therapy Nuvigil (ingredient: armodafini...
by Marian Chu  |  2018-06-01 12:06
라인
Korea United Pharm wages war on Chinese fake capsules
Korea United Pharm said it would seek compensation for damages against a Ch...
by So Jae-hyeon  |  2018-06-01 12:05
라인
YUHS, Celltrion to develop next-generation stroke therapy
Researchers from Yonsei University Health System (YUHS) will work with Cell...
by Marian Chu  |  2018-05-31 18:01
라인
Novartis Korea launches 2nd generation acromegaly therapy
Signifor LAR (pasireotide pamoate) Source: Korea Pharmaceutical Informati...
by Marian Chu  |  2018-05-31 17:48
라인
Leo Pharma Korea launches Enstilum foam for psoriasis
Enstilum foam Leo Pharma Korea has launched a spray-on, topical treatment...
by Marian Chu  |  2018-05-31 17:47
라인
OCI enters pharma sector via joint venture with Bukwang
Chemicals and energy firm OCI has announced that it would enter the pharmac...
by So Jae-hyeon  |  2018-05-31 15:38
여백
여백
여백
Back to Top